BIORESTORATIVE THERAPIES, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- BIORESTORATIVE THERAPIES, INC. payments for repurchase of common stock for the quarter ending 2026-03-31 was $0.00.
- BIORESTORATIVE THERAPIES, INC. payments for repurchase of common stock for the quarter ending 2014-03-31 was $0.00.
- BIORESTORATIVE THERAPIES, INC. payments for repurchase of common stock for the quarter ending 2013-12-31 was $0.00.
- BIORESTORATIVE THERAPIES, INC. payments for repurchase of common stock for the quarter ending 2013-09-30 was $0.00.
- BIORESTORATIVE THERAPIES, INC. payments for repurchase of common stock for fiscal 2025 was $0.00.
- BIORESTORATIVE THERAPIES, INC. payments for repurchase of common stock for fiscal 2013 was $0.00.
- BIORESTORATIVE THERAPIES, INC. payments for repurchase of common stock for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- BIORESTORATIVE THERAPIES, INC. payments for repurchase of common stock for fiscal 2011 was $4.00K, a 85.71% decline from fiscal 2010.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $0.00 10-K · filed 2026-03-26 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-11 | $0.00 10-K · filed 2014-04-11 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-19 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-11 | $0.00 10-K · filed 2014-04-11 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | $4.00K derived: sum of 4 quarters · filed 2013-11-19 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-19 | $4.00K derived: sum of 4 quarters · filed 2013-08-19 |
| 2012-03-31 | $0.00 10-Q · filed 2013-05-15 | |
| 2011-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-02 | $4.00K 10-K · filed 2013-04-02 |
| 2011-09-30 | $0.00 derived: 10-Q 33 month − 10-Q/A 30 month · filed 2011-11-21 | |
| 2010-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $28.00K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |